Search research articles
Contact Us
Filters
Showing results (151-160 of 198) with videos related to
Page
of 20
Sort By:
Journal of Personalized Medicine
|
December 24, 2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis
Alireza Sharafshah, Kenneth Blum, Kai-Uwe Lewandrowski, et al.
Journal of Personalized Medicine
|
September 23, 2022
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control Subjects
Kenneth Blum, David Han, Ashim Gupta, et al.
Journal of Personalized Medicine
|
December 29, 2022
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index
Kenneth Blum, David Han, Abdalla Bowirrat, et al.
Journal of Personalized Medicine
|
December 23, 2022
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, et al.
American Journal of Lifestyle Medicine
|
January 12, 2026
Lifestyle Interventions for Major Depressive Disorder (MDD): An Expert Consensus Statement From the American College of Lifestyle Medicine
Gia Merlo, Steve Sugden, Richard M Rosenfeld, et al.
Frontiers in Bioscience (Elite Edition)
|
September 21, 2017
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence
Kenneth Blum, Amanda L C Chen, Panayotis K Thanos, et al.
Journal of the Neurological Sciences
|
September 9, 2022
Why haven't we solved the addiction crisis?
Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, et al.
International Journal of Genomics and Data Mining
|
September 11, 2018
The Benefits of Genetic Addiction Risk Score (GARS
Kenneth Blum, Edward J Modestino, Marjorie Gondre-Lewis, et al.
Journal of Personalized Medicine
|
February 25, 2022
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?
Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
EC Psychology and Psychiatry
|
June 26, 2023
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors
Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 198) with videos related to
Sort By:
Page
of 20
Journal of Personalized Medicine
|
December 24, 2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis
Alireza Sharafshah, Kenneth Blum, Kai-Uwe Lewandrowski, et al.
Journal of Personalized Medicine
|
September 23, 2022
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case-Control Subjects
Kenneth Blum, David Han, Ashim Gupta, et al.
Journal of Personalized Medicine
|
December 29, 2022
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index
Kenneth Blum, David Han, Abdalla Bowirrat, et al.
Journal of Personalized Medicine
|
December 23, 2022
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, et al.
American Journal of Lifestyle Medicine
|
January 12, 2026
Lifestyle Interventions for Major Depressive Disorder (MDD): An Expert Consensus Statement From the American College of Lifestyle Medicine
Gia Merlo, Steve Sugden, Richard M Rosenfeld, et al.
Frontiers in Bioscience (Elite Edition)
|
September 21, 2017
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence
Kenneth Blum, Amanda L C Chen, Panayotis K Thanos, et al.
Journal of the Neurological Sciences
|
September 9, 2022
Why haven't we solved the addiction crisis?
Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, et al.
International Journal of Genomics and Data Mining
|
September 11, 2018
The Benefits of Genetic Addiction Risk Score (GARS
Kenneth Blum, Edward J Modestino, Marjorie Gondre-Lewis, et al.
Journal of Personalized Medicine
|
February 25, 2022
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?
Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
EC Psychology and Psychiatry
|
June 26, 2023
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors
Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
Page
of 20